3 results
Approved WMORecruiting
To assess the efficacy and safety of LCI699 in CD patients
Approved WMOCompleted
The objective of this investigation is to describe visual outcomes and assess the safety at 12 months (330 - 420 days) post bilateral implantation of the AcrySof® IQ PanOptix* Presbyopia correcting IOL Model TFNT00.
Approved WMOCompleted
Collect data in an observational study on outcomes of endovascular fistula creation using the everlinQ endoAVF System